The Latest Cardiac and Vascular News
The DETOUR 2 study is a prospective, single-arm, international, multi-center clinical evaluation of the novel DETOUR™ System for fully percutaneous femoropopliteal bypass procedures. IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company dedicated to improving patients’ lives with innovative interventional treatments for vascular disease, recently announced the 12-month […]
PRAIRIE VILLAGE, Kan., June 23, 2022 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the appointment of veteran medical device executive Joseph Ingoglia as Chief Commercial Officer. Ingoglia will be responsible for building Artio’s sales and marketing teams and driving revenue […]
Seasoned healthcare executive added as Bodyport commercial efforts ramp up SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions, announced today the appointment of Jim Pursley to the company’s board of directors. “I am excited to join the Bodyport Board of Directors as […]
Accomplished MedTech Leader with Proven Track Record of Strategic, Operational and Commercial Execution in High Growth Companies SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure (HF), today announced that Mark Miles has joined the company as Chief Commercial Officer (CCO). He […]
Study Intends to Demonstrate that Ultrasound Allows for Precise Deployment and Positive Positioning of the MANTA® Vascular Closure Device WAYNE, Pa., June 22, 2022 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study that is […]
HANGZHOU, China, June 22, 2022 /PRNewswire/ — VenusP-Valve™, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as “Venus Medtech”), recently completed its first compassionate use at University of Virginia Advanced Cardiac Valve Center in the U.S. The procedure was performed at the Center by Professor Scott Lim’s team under […]
Scientists develop a roadmap to future personalized medicine for heart defects that develop before birth HOUSTON, June 22, 2022 /PRNewswire/ — A team of investigators from Texas Heart Institute, Texas Children’s Hospital and Baylor College of Medicine uncovered new insights into the mechanisms underlying the progression of congenital heart disease (CHD) ― a spectrum […]
BOSTON, June 22, 2022 /PRNewswire/ — Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round. The round was led by an undisclosed strategic investor, with participation from Biovision Ventures, a new Europe-based fund, and existing investors, including MedTex Ventures, IAG […]
Leading Center of Excellence will participate in a 60-day evaluation of The Company’s signal processing technology Westport, CT, June 22, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal […]
Press release Malmö, Sweden, June 22, 2022 Acarix partners with Strategic Health AK to roll-out CADScor®System across the state of Alaska Acarix continues its US expansion by partnering with Strategic Health AK, a healthcare provider covering tribal and rural areas of Alaska. Acarix has received initial orders of CADScor®Systems to […]
